B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • RnM3784338
  • |
  • 26 September, 2019
  • |
  • 147 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$10,995.00
$21,990.00
$32,985.00
8,850.98
17,701.95
26,552.93
10,632.16
21,264.33
31,896.50
1,666,732.05
3,333,464.10
5,000,196.15
964,041.60
1,928,083.20
2,892,124.80
Credit card Logo